In August 2014, CarePilot USA, based in Newport Beach, California, announced a collaboration with the “Cord for Life” storage program offered by Lifeforce Cryobanks, a company based in Altamonte Springs, Florida. Through this partnership, CarePilot is now offering significant discounts on the collection, processing, and storage of newborn umbilical cord blood. Specifically, CarePilot is offering two, six, and 21-year storage plans at major discounts relative to the market rates offered by the “Cord for Life” program. [Read more…]
Strategy of the Day: How to Efficiently Convert Cord Blood Banking Leads to Clients
For cord blood banks that are marketing to expectant parents, the time window during which to convert a lead to a client is only nine months at best, often shorter, if an expectant couple does not contact you immediately after becoming aware of the pregnancy.
Under these circumstances, what is the best way to follow-up with your potential clients? [Read more…]
As the cord blood banking marketplace has matured and attracted a wide range of industry participants, a variety of conferences and events to support the industry have also emerged, both in the United States and worldwide. Most of these conferences focus on the technical, ethical, and professional aspects of running cord blood banking businesses, but there are speakers that share research advances related to cord blood stem cells and cord blood transplant methodology.
The past few years have seen increasing investments made within the cord blood banking market, both by private equity and venture capital firms. These investments show the strength of the cord blood banking market. A summary of these investors is shown below.
There have also been significant acquisitions made within the cord blood industry, with the largest cord blood bank within the United States, Cord Blood Registry, recently acquired by AMAG Pharmaceuticals in June of 2015 for $700 million. The purchase valued Cord Blood Registry at over 5.55 times revenue and over 15.55 times EBITDA. [Read more…]
AUTHOR: Authored by Wendy Roberts, PR Director of Orca Communications Unlimited, LLC.
COMMENT BY BIOINFORMANT: Leading global players within cord blood industry frequently attain their industry dominance through industry collaborations. In the announcement below, released May 11, 2015, CariCord and ClinImmune Labs announce a major industry partnership that will study the survivability of umbilical cord blood stem cells under micro gravity (Micro-G) simulation.
CariCord, a private stem cell bank at the University of Colorado, is a FDA-licensed cord blood manufacturer that has processed nearly 9,000 cord blood units and released 700+ for transplantation across 150+ hospitals worldwide. While CariCord is not as substantial in size as other key players within the U.S. cord blood industry (most notably Cord Blood Registry, ViaCord, and Cryo-Cell, respectively) the company is positioning itself for increased visibility and growth through this strategic collaboration. [Read more…]